drugset / Trial / NCT03149887
Liposomal Bupivacaine After Arthroscopic Rotator Cuff Repair
RandomizedParallel-groupQuadruple-blindSupportive care
Summary
Liposomal bupivacaine, a long-acting form of bupivacaine, has been found to be effective for postoperative pain control after total knee, total hip and total shoulder arthroplasty. We are conducting a randomized, controlled trial to evaluate pain control after arthroscopic rotator cuff repair in ambulatory patients, comparing standard care in the control group, with standard care plus the addition of injection of liposomal bupivacaine in the experimental group.
Timeline
- Start
- 2017-12-05
- Primary completion
- 2019-02-26
- Completion
- 2019-03-01
Outcome
Missed primary endpoint
registry analysis (superiority test); Experimental (Liposomal Bupivacaine) vs Control (Normal Saline); p = 0.66; t-test, 2 sided NCT03149887 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 266 mg | Other |